References
- Tanchev Y., Dorossiev H. The first clinical description of Balkan endemic nephropathy 1956 and its validity 35 years later. International Agency for Research of Cancer. IARC Lyon. 1991; 71
- Stefanovic V., Polenakovic M. H. Balkan Nephropathy. Kidney Disease beyond the Balkans?. Editorial. Am. J. Nephrol. 1991; 11: 1
- Gluhovschi G., Stefanovic V., Dimitrov T., Drugarin D., Trandafirescu V., Schiller A., Petrica L., Poll N. Endemic Balkan Nephropathy. Editura Helicon. Timisoara. 1994
- Strahinjic S., Stefanovic V. Clinical feature and diagnosis of endemic nephropathy. Proceedings of the 6th Symposium on Endemic (Balkan) Nephropathy Nis. University Press Nis, 1987; 1
- Mihailov T. New phenomena in the genealogical study of Balkan endemic nephropathy in Bulgaria in Strahinlic Stefanovic: Endemic (Balkan) nephrophaty. University Press Nis, 1979; 253
- Curcic B., Pasic I., Halilbasic A., Martinovic K. Correlation of particular blood groups and the incidence fo endemic (Balkan) nephropathy in the population of the endemic region of Bosanski Samac II. Current research in endemic nephropathy. University Press Nis. 1983; 35
- Minev M., Mikhaylov T., Kastelan A., Nylassy S., Menzel G. HLA‐System and Balkan Endemic nephropathy. Tissue Antigens. 1978; 11: 50
- Tonceva D., Dimitrov T., Tzoneva M. Cytogenetic studies in Balkan endemic nephropathy. Nephron. 1988; 48: 18
- Apostolov K., Spasic P., Boyanic N. Evidence of a viral etiology in endemic (balkan) nephropathy. Lancet II. 1975; 1271
- Vizjac A., Trnacevic S., Ferluga D., Hallilbasis A. (1991): Renal function, protein excretion and pathology of Balkan endemic nephropathy IV. Immunohistology. Kidney Int. 1991; 34(40. suppl.)S68
- Belovezhoov N. Cell mediated autoimmunity in patients with endemic nephropathy. Documenta Galenika Beograd. 1977; 192
- Hudson L., Hay F. Practical immunologyThird Edition. 1992
- Pesce A. J., Kaplan L. A. Methods in Clinical Chemistry. 1987
- Stites D., Terr A., Parslow T. Basic and Clinical ImmunologyEighth Edition. 1994
- Rose N., Bona C. A. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today. 1993; 14(9)426–430
- Bona C. A., Siminovitch K. A., Zanetti M. Theofilopoulos. The Molecular pathology of autoimmune diseases. Harwood Academic Publishers. 1993
- Lanier L. L., Kipps T. J., Phillips J. H. Functional proprieties of a unique subset of cytotoxic CD3 + T lymphocytes that express Fc receptors for IgG (CD16/Leu‐11 antigen). J. Exp. 1985; 162: 2089–2106
- Koysau S. CD3 + CD16+ NK1.1 + Large granular lymphocytes arise from both αβ TCR + CD4− CD8−and τδ TCR+ CD4− CD8− cells. J. Exp. 1994; 179: 1957–1972
- Coles M. C., Raulet D. H. Class I dependence of the development of CD4+ CD8− NK1.1 + thymocytes. J. EXP. 1994; 180: 395–399
- Bendalec A., Lantz O., Quimby M. E., Yewdell J. W., Bennink J. H., Brutkiewicz R. R. CD1 recognition by mouse NK 1 + T lymphocytes. Science 1995; 268: 863–865
- Rodewald H. R., Moingeon P., Lucich J. L., Dosion C., Lopez P., Reinherz E. L. A population of early fetal thymocytes expressing Fc τ R II/III contains precursors of T lymphocytes and natural killer cells. Cell. 1992; 69: 139–148
- Bendlac A., Killen N., Litthan D. R., Schwartz R. A. subset of CD4+ tymocytes selected by MHC class I molecules. Science 1994; 263: 1774–1778
- Malnati M. S., Peruzzi M., Parker K. C., Biddison W. E., et al. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995; 267: 1016–1018
- Castano A. R., Tangri S., Miller J. E., Holcombe H., Jackson M., et al. Peptide binding and presentation by mouse CD1. Science 1995; 269: 223–226
- Drugarin D., Gluhovski G., Anghel S., Margineau F., Noveanu L., Paunescu V., Maties R. Immunological Alteration in Balkan nephropathy. Rom. Arch. Microbiol. Immunol. 1994; 53(3)175–186